A new strain of flu pandemic flu vaccine is being tested in a Colorado community, and the city is getting its first batch.
The city is partnering with Colorado State University to get its first round of testing, which could start as early as the middle of August.
The first batch of the new vaccine will come from the company Biogen, which was acquired by Abbott Laboratories for $750 million.
The vaccine, which the company says is effective against influenza, has a 60% success rate.
The company says the vaccine will be administered in a series of four doses.
The vaccine will not be sold by the city, but it will be available for purchase in grocery stores and pharmacies.
The City Council voted to make it an ordinance on Tuesday.
The vote also allows for the city to continue using the vaccine.
In the event of a pandemic, if you’re experiencing symptoms, your doctor may recommend that you get the vaccine to keep you healthy.
The federal government estimates that more than 7.4 million people in the U.S. are infected with flu, and more than half of them are in their 50s or older.